Ghent University Academic Bibliography

Your filters: cql: author exact F50FCA64-F0ED-11E1-A9DE-61C894A0A6B4

Add to list
- Journal Article
- A2
- open access
Case series of kaposi sarcoma in HIV-negative men who have sex with men : potential therapeutic approaches

Niels Hilhorst (UGent) , Barbara Devocht, Evelien Verhaeghe (UGent) , Lore Lapeire (UGent) , Linos Vandekerckhove (UGent) , Soetkin Desmet, Marie-Angélique De Scheerder (UGent) and Lieve Brochez (UGent)

(2024) JOURNAL OF DERMATOLOGY RESEARCH AND THERAPY. 10(1). p.1-6
Add to list
- Journal Article
- A1
Cost-of-illness of skin cancer : a systematic review

Annick Meertens (UGent) , Laura Van Coile (UGent) , Tijs Van Iseghem (UGent) , Lieve Brochez (UGent) , Nick Verhaeghe (UGent) and Isabelle Hoorens (UGent)

(2024) PHARMACOECONOMICS. 42(7). p.751-765
Add to list
- Journal Article
Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them.

Claus Garbe, Ana-Maria Forsea, Teresa Amaral, Petr Arenberger, Philippe Autier, Marianne Berwick, Brigitta Boonen, Matilda Bylaite, Veronique del Marmol, Brigitte Dreno, et al.

(2024) European Journal of Cancer. 204.
Add to list
- Journal Article
The Value of Teledermatology Advice for Skin Toxicity in Oncology: Experience From a Pilot Study

Sofie Mylle, Jorien Papeleu, Isabelle Hoorens (UGent) , Evelien Verhaeghe (UGent) and Lieve Brochez (UGent)

(2024) JMIR Dermatology. 7.
Add to list
- Miscellaneous
Angiosarcoma mimicking rhinophyma

Niels Hilhorst (UGent) , Evelien Verhaeghe (UGent) and Lieve Brochez (UGent)

(2023) JAMA DERMATOLOGY. 159(1). p.95-95
Add to list
- Journal Article
- A1
Dermatologist versus artificial intelligence confidence in dermoscopy diagnosis : complementary information that may affect decision-making

Pieter Van Molle (UGent) , Sofie Mylle (UGent) , Tim Verbelen (UGent) , Cedric De Boom, Bert Vankeirsbilck (UGent) , Evelien Verhaeghe (UGent) , Bart Dhoedt (UGent) and Lieve Brochez (UGent)

(2023) EXPERIMENTAL DERMATOLOGY. 32(10). p.1744-1751
Add to list
- Journal Article
- A1
- open access
Comparative analysis of cooling methods for dynamic infrared thermography (DIRT)-based skin cancer diagnosis

Jan Verstockt, Filip E. F. Thiessen, Isabelle Hoorens (UGent) , Lieve Brochez (UGent) and Gunther Steenackers

(2023) APPLIED SCIENCES-BASEL. 13(18).
Add to list
- Journal Article
- A1
- open access
Impact of the COVID-19 pandemic on the incidence and thickness of cutaneous melanoma in Belgium

Philip Georg Demaerel, Arthur Leloup, Lieve Brochez (UGent) , Liesbet Van Eycken and Marjan Garmyn

(2023) BIOMEDICINES. 11(6).
Add to list
- Journal Article
- A1
- open access
Can multispectral dermoscopy help in distinguishing blue color?

Laudine Janssen, Sofie Van Kelst, Bart Diricx, Tom Kimpe, Jorien Papeleu, Evelien Verhaeghe (UGent) , Lieve Brochez (UGent) and Marjan Garmyn

(2023) DERMATOLOGY PRACTICAL & CONCEPTUAL. 13(1).
Add to list
- Journal Article
- A1
- open access
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023

Ketty Peris, Maria Concetta Fargnoli, Roland Kaufmann, Petr Arenberger, Lars Bastholt, Nicole Basset Seguin, Veronique Bataille, Lieve Brochez (UGent) , Veronique del Marmol, Reinhard Dummer, et al.

(2023) EUROPEAN JOURNAL OF CANCER. 192.
Add to list
- Conference Paper
- C3
Cost-of-illness of skin cancer : a systematic literature review

Annick Meertens (UGent) , Laura Van Coile (UGent) , Tijs Van Iseghem (UGent) , Lieve Brochez (UGent) , Nick Verhaeghe (UGent) and Isabelle Hoorens (UGent)

(2023) VALUE IN HEALTH. In Value in Health 26(12, Supplement). p.S542-S542
Add to list
- Journal Article
- A1
Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial

Mathieu Spaas (UGent) , Nora Sundahl, Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Daan De Maeseneer (UGent) , Fréderic Duprez (UGent) , Yolande Lievens (UGent) , Veerle Surmont (UGent) , Lieve Brochez (UGent) , Dries Reynders (UGent) , et al.

(2023) JAMA ONCOLOGY. 9(9). p.1205-1213
Add to list
- Journal Article
- A1
Truth or dare : switching BRAF/MEK inhibitors after acute interstitial nephritis in a patient with metastatic melanoma : a case report and review of the literature

Lore De Ryck, Sigurd Delanghe (UGent) , Celine Jacobs (UGent) , Sharareh Fadaei (UGent) , Lieve Brochez (UGent) and Michael Saerens (UGent)

(2023) ACTA CLINICA BELGICA. 78(3). p.215-222
Add to list
- Journal Article
- A1
The therapeutic dilemma of basal cell carcinoma in older adults : a review of the current literature

Laura Van Coile (UGent) , Evelien Verhaeghe (UGent) , Katia Ongenae (UGent) , Laura Destrooper, Zahra Mohamadi, Lieve Brochez (UGent) and Isabelle Hoorens (UGent)

(2023) JOURNAL OF GERIATRIC ONCOLOGY. 14(3).
Add to list
- Journal Article
- A1
A critical re‐evaluation of Mohs micrographic surgery for a facial basal cell carcinoma in older adults : should we waive this treatment in certain patients?

Laura Van Coile (UGent) , Lieve Brochez (UGent) , Evelien Verhaeghe (UGent) , Barbara Boone (UGent) , Annick Meertens (UGent) , Katia Ongenae (UGent) and Isabelle Hoorens (UGent)

(2023) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 37(9). p.1792-1798
Add to list
- Journal Article
- A1
- open access
Study protocol of the BASINEL Study : a pragmatic randomised controlled trial investigating treatment versus no treatment of low-risk basal cell carcinomas in older persons

Laura Van Coile (UGent) , Evelien Verhaeghe (UGent) , Katia Ongenae (UGent) , Lieve Brochez (UGent) and Isabelle Hoorens (UGent)

(2022) BMJ OPEN. 12(11).
Add to list
- Journal Article
- A1
Response to the comment by Suijkerbuijk et al. ‘Survival of stage IV melanoma in Belgium and the Netherlands’

B. Reyn, E. Van Eycken, M. Louwman, K. Henau, K. Schreuder, Lieve Brochez (UGent) , M. Garmyn and N.A. Kukutsch

(2022) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 36(2). p.E119-E119
Add to list
- Miscellaneous
- open access
Basal cell carcinoma in older adults : how to decide when active surveillance or watchful waiting are appropriate?

Laura Van Coile (UGent) , Evelien Verhaeghe (UGent) , Katia Ongenae (UGent) , Lieve Brochez (UGent) and Isabelle Hoorens (UGent)

(2022) BRITISH JOURNAL OF DERMATOLOGY. 187(2). p.244-245
Add to list
- Journal Article
- A1
- open access
Health state utility instruments in patients with keratinocyte cancer and actinic keratosis : a cross‐sectional study

Isabelle Hoorens (UGent) , R. Waalboer‐Spuij, Laura Van Coile (UGent) , M. Debaveye, Andrew Shen, Evelien Verhaeghe (UGent) and Lieve Brochez (UGent)

(2022) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 36(11). p.e906-e907
Add to list
- Journal Article
- A1
- open access
Skin cancer detection using infrared thermography : measurement setup, procedure and equipment

Jan Verstockt, Simon Verspeek, Filip Thiessen, Wiebren A. Tjalma, Lieve Brochez (UGent) and Gunther Steenackers

(2022) SENSORS. 22(9).
Add to list
- Miscellaneous
- open access
Systemic treatment of advanced basal cell carcinoma : how to critically evaluate value for patient and society?

Isabelle Hoorens (UGent) , Laura Van Coile (UGent) , Celine Jacobs (UGent) , Michael Saerens (UGent) , Evelien Verhaeghe (UGent) and Lieve Brochez (UGent)

(2022) THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 14.
Add to list
- Journal Article
- A1
The value of measuring uncertainty in neural networks in dermoscopy

Pieter Van Molle (UGent) , Lieve Brochez (UGent) , Tim Verbelen (UGent) , Cedric De Boom, Bert Vankeirsbilck (UGent) , Evelien Verhaeghe (UGent) , Sofie Mylle (UGent) , Pieter Simoens (UGent) and Bart Dhoedt (UGent)

(2022) JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 87(5). p.1191-1193
Add to list
- Conference Paper
- C3
Towards the discovery of prognostic and predictive biomarkers in CHEERS, a radioimmunotherapy phase II trial

Jan Vanwelkenhuyzen (UGent) , Mathieu Spaas (UGent) , Kim Van der Eecken (UGent) , Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Lieve Brochez (UGent) , Johan Lindberg, Katleen De Preter (UGent) , Bram De Laere (UGent) and Piet Ost (UGent)

(2022) OncoPoint Symposium, 8th, Abstracts.
Add to list
- Journal Article
- A1
- open access
High-resolution 18F-FDG PET/CT for assessing three-dimensional intraoperative margins status in malignancies of the head and neck, a proof-of-concept

Jens Debacker (UGent) , Vanessa Schelfhout (UGent) , Lieve Brochez (UGent) , David Creytens (UGent) , Yves D'Asseler (UGent) , Philippe Deron (UGent) , Vincent Keereman (UGent) , Koen Van de Vijver (UGent) , Christian Vanhove (UGent) and Wouter Huvenne (UGent)

(2021) JOURNAL OF CLINICAL MEDICINE. 10(16).
Add to list
- Journal Article
- A1
- open access
Immune monitoring in melanoma and urothelial cancer patients treated with anti-PD-1 immunotherapy and SBRT discloses tumor specific immune signatures

Annabel Meireson, Simon Tavernier (UGent) , Sofie Van Gassen (UGent) , Nora Sundahl, Annelies Demeyer (UGent) , Mathieu Spaas (UGent) , Vibeke Kruse (UGent) , Liesbeth Ferdinande (UGent) , Jo Van Dorpe (UGent) , Benjamin Hennart, et al.

(2021) CANCERS. 13(11).
Add to list
- Journal Article
- A1
- open access
Lesion‐directed screening to optimize skin cancer detection in dermatology practice : an observational study

Sofie Mylle (UGent) , Evelien Verhaeghe (UGent) , Laura Van Coile (UGent) , Beatrice Van de Maele, Isabelle Hoorens (UGent) and Lieve Brochez (UGent)

(2021) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 35(6). p.1309-1314
Add to list
- Conference Paper
- C3
Three-dimensional margin assessment in head and neck malignancies using a submillimetric 18F-FDG PET/CT, results of an ongoing clinical trial

Jens Debacker (UGent) , David Creytens (UGent) , Lieve Brochez (UGent) , Yves D'Asseler (UGent) , Philippe Deron (UGent) , Nicolas Dhooghe (UGent) , Frederick Dochy, Vincent Keereman (UGent) , Vanessa Schelfhout (UGent) , Peter Tomassen (UGent) , et al.

(2021) ORAL ONCOLOGY. 118(Suppl.). p.5-5
Add to list
- Journal Article
- A1
- open access
Clinical relevance of serum Kyn/Trp ratio and basal and IFN gamma-upregulated IDO1 expression in peripheral monocytes in early stage melanoma

Annabel Meireson, Liesbeth Ferdinande (UGent) , Marc Haspeslagh (UGent) , Benjamin Hennart, Delphine Allorge, Piet Ost (UGent) , Nora Sundahl, Mathieu Spaas (UGent) , Annelies Demeyer (UGent) and Lieve Brochez (UGent)

(2021) FRONTIERS IN IMMUNOLOGY. 12.
Add to list
- Journal Article
- A1
Incidence and survival of cutaneous melanoma in Belgium and the Netherlands from 2004 to 2016 : striking differences and similarities of two neighbouring countries

B. Reyn, E. Van Eycken, M. Louwman, K. Henau, K. Schreuder, Lieve Brochez (UGent) , M. Garmyn and N.A. Kukutsch

(2021) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 35(7). p.1528-1535
Add to list
- Miscellaneous
- open access
Editorial : targeting indoleamine 2,3-dioxygenases and tryptophan dioxygenase for cancer immunotherapy

Lieve Brochez (UGent) , Vibeke Kruse, Dirk Schadendorf, Alexander J. Muller and George C. Prendergast

(2021) FRONTIERS IN IMMUNOLOGY. 12.
Add to list
- Journal Article
- A2
Phototoxicité sous olanzapine et acide valproïque : rapport de cas et revue de la littérature sur les effets secondaires au niveau cutané suite aux antipsychotiques atypiques et à l'acide valproïque

Hannes Dechamps, Lieve Brochez (UGent) , Luk Beelaert, Celine Matton (UGent) and Gilbert Lemmens (UGent)

(2021) ACTA PSYCHIATRICA BELGICA. 121(3). p.19-27
Add to list
- Journal Article
- A1
- open access
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Mathieu Spaas (UGent) , Nora Sundahl, Eva Hulstaert, Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Daan De Maeseneer (UGent) , Veerle Surmont (UGent) , Annabel Meireson, Lieve Brochez (UGent) , Dries Reynders (UGent) , et al.

(2021) BMC CANCER. 21(1).
Add to list
- Miscellaneous
- open access
Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic

Lieve Brochez (UGent) , J.F. Baurain, V. Del Marmol, A. Nikkels, Vibeke Kruse (UGent) , F. Sales, M. Stas, A. Van Laethem and M. Garmyn

(2020) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 34(9). p.1876-1878
Add to list
- Journal Article
- A1
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases

Yanina Jansen, Vibeke Kruse (UGent) , Jurgen Corthals, Kelly Schats, Pieter-Jan van Dam, Teofila Seremet, Carlo Heirman, Lieve Brochez (UGent) , Mark Kockx, Kris Thielemans, et al.

(2020) CANCER IMMUNOLOGY IMMUNOTHERAPY. 69(12). p.2589-2598
Add to list
- Journal Article
- A1
The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype

Niels Vandamme (UGent) , Geertrui Denecker (UGent) , Kenneth Bruneel, Gillian Blancke (UGent) , Ozden Akay, Joachim Taminau (UGent) , Jordy De Coninck (UGent) , Eva De Smedt (UGent) , Nicolas Skrypek (UGent) , Wouter Van Loocke (UGent) , et al.

(2020) CANCER RESEARCH. 80(14). p.2983-2995
Add to list
- Journal Article
- A1
- open access
IDO expression in cancer : different compartment, different functionality?

Annabel Meireson, Michael Devos and Lieve Brochez (UGent)

(2020) FRONTIERS IN IMMUNOLOGY. 11.
Add to list
- Journal Article
- A1
Enhanced visualization of blood and pigment in multispectral skin dermoscopy

Laudine Janssen, Sofie Mylle (UGent) , Sofie Van Kelst, Julie De Smedt, Bart Diricx, Tom Kimpe, Marc Boone, Evelien Verhaeghe (UGent) , Lieve Brochez (UGent) and Marjan Garmyn

(2020) SKIN RESEARCH AND TECHNOLOGY. 26(5). p.708-712
Add to list
- Journal Article
- A1
- open access
Charting extracellular transcriptomes in the human biofluid RNA atlas

Eva Hulstaert, Annelien Morlion (UGent) , Francisco Avila Cobos (UGent) , Kimberly Verniers (UGent) , Justine Nuytens (UGent) , Eveline Vanden Eynde (UGent) , Nurten Yigit (UGent) , Jasper Anckaert (UGent) , Anja Geerts (UGent) , Pieter Hindryckx (UGent) , et al.

(2020) CELL REPORTS. 33(13).
Add to list
- Miscellaneous
Haptoglobin polymorphism and the risk of actinic keratoses and cutaneous squamous cell carcinoma: A case-control study

Lieve Brochez (UGent) , Reinhart Speeckaert (UGent) , Dirk De Bacquer (UGent) , Joris Delanghe (UGent) and Isabelle Hoorens (UGent)

(2019) JOURNAL OF DERMATOLOGY. 46(3). p.274-275
Add to list
- Journal Article
- A1
Phase 2 trial of nivolumab combined with stereotactic body radiation therapy in patients with metastatic or locally advanced inoperable melanoma

Nora Sundahl, Teofila Seremet, Jo Van Dorpe (UGent) , Bart Neyns, Liesbeth Ferdinande, Annabel Meireson, Lieve Brochez (UGent) , Vibeke Kruse (UGent) and Piet Ost (UGent)

(2019) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 104(4). p.828-835
Add to list
- Conference Paper
- C3
Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results

Piet Ost (UGent) , Nora Sundahl, G Vandekerkhove, Karel Decaestecker (UGent) , Annabel Meireson, Pieter De Visschere (UGent) , Valerie Fonteyne (UGent) , Daan De Maeseneer (UGent) , Dries Reynders (UGent) , Els Goetghebeur (UGent) , et al.

(2019) EUROPEAN UROLOGY SUPPLEMENTS. 18(1). p.e2105-e2105
Add to list
- Conference Paper
- C3
Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma : clinical and translational results

Gillian Vandekerkhove, Nora Sundahl, Karel Decaestecker (UGent) , Annabel Meireson, Pieter De Visschere (UGent) , Valerie Fonteyne (UGent) , Daan De Maeseneer (UGent) , Dries Reynders (UGent) , Els Goetghebeur (UGent) , Jo Van Dorpe (UGent) , et al.

(2019) JOURNAL OF CLINICAL ONCOLOGY. 37(7, suppl. 5).
Add to list
- Conference Paper
- C3
Assessing uncertainty for computer assisted skin lesion diagnosis

Pieter Van Molle (UGent) , Tim Verbelen (UGent) , Bert Vankeirsbilck (UGent) , Sofie Mylle, Evelien Verhaeghe (UGent) , Lieve Brochez (UGent) , Jonas De Vylder (UGent) , Bart Diricx, Pieter Simoens (UGent) and Bart Dhoedt (UGent)

(2019) EADV, 28th Congress, Abstracts.
Add to list
- Journal Article
- A1
- open access
Value of dermoscopy in a population-based screening sample by dermatologists

Isabelle Hoorens (UGent) , Katrien Vossaert (UGent) , Sven Lanssens, Laurence Dierckxsens, Giuseppe Argenziano and Lieve Brochez (UGent)

(2019) DERMATOLOGY PRACTICAL & CONCEPTUAL. 9(3). p.200-206
Add to list
- Journal Article
- A1
Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma

Nora Sundahl, Gillian Vandekerkhove, Karel Decaestecker (UGent) , Annabel Meireson, Pieter De Visschere (UGent) , Valerie Fonteyne (UGent) , Daan De Maeseneer (UGent) , Dries Reynders (UGent) , Els Goetghebeur (UGent) , Jo Van Dorpe (UGent) , et al.

(2019) EUROPEAN UROLOGY. 75(5). p.707-711
Add to list
- Conference Paper
- C3
- open access
A study on confidence in classification of skin lesions by deep neural networks

Pieter Van Molle (UGent) , Tim Verbelen (UGent) , Bert Vankeirsbilck (UGent) , Sofie Mylle (UGent) , Evelien Verhaeghe (UGent) , Lieve Brochez (UGent) , Jonas De Vylder, Bart Diricx, Pieter Simoens (UGent) and Bart Dhoedt (UGent)

(2019) OncoPoint, 7th Research seminar, Abstracts.
Add to list
- Conference Paper
- C3
A study on confidence in classification of skin lesions by deep neural networks

Pieter Van Molle (UGent) , Tim Verbelen (UGent) , Bert Vankeirsbilck (UGent) , Sofie Mylle (UGent) , Evelien Verhaeghe (UGent) , Lieve Brochez (UGent) , Jonas De Vylder, Bart Diricx, Pieter Simoens (UGent) and Bart Dhoedt (UGent)

(2019) European Association of Dermato-Oncology, 15th Congress, Abstracts.
Add to list
- Journal Article
- A1
- open access
Immune checkpoint blockade for organ transplant patients with advanced cancer : how far can we go?

Pauline De Bruyn, Dirk Van Gestel, Piet Ost (UGent) , Vibeke Kruse (UGent) , Lieve Brochez (UGent) , Hans Van Vlierberghe (UGent) , Arnaud Devresse, Véronique del Marmol, Alain Le Moine and Sandrine Aspeslagh

(2019) CURRENT OPINION IN ONCOLOGY. 31(2). p.54-64
Add to list
- Journal Article
- A2
Algorithms for molecular testing in solid tumours

A. Hébrant, M. Lammens, C. Van den Broecke, N. D’Haene, J. Van den Oord, A. Vanderstichele, A. Dendooven, P. Neven, K. Punie, G. Floris, et al.

(2019) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 13(7). p.286-295
Add to list
- Conference Paper
- C3
Endothelial indoleamine 2,3-dioxygenase is correlated with microsatellite status in colorectal carcinoma and predicts worse prognosis

Annabel Meireson, INES CHEVOLET (UGent) , Eva Hulstaert, Liesbeth Ferdinande (UGent) , Piet Ost (UGent) , Karen Geboes (UGent) , Marc De Man, Dirk Van de Putte, Laurine Verset, Vibeke Kruse (UGent) , et al.

(2018) OncoPoint, 6th Research seminar, Abstracts.

Case series of kaposi sarcoma in HIV-negative men who have sex with men : potential therapeutic approaches

Cost-of-illness of skin cancer : a systematic review

Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them.

The Value of Teledermatology Advice for Skin Toxicity in Oncology: Experience From a Pilot Study

Angiosarcoma mimicking rhinophyma

Dermatologist versus artificial intelligence confidence in dermoscopy diagnosis : complementary information that may affect decision-making

Comparative analysis of cooling methods for dynamic infrared thermography (DIRT)-based skin cancer diagnosis

Impact of the COVID-19 pandemic on the incidence and thickness of cutaneous melanoma in Belgium

Can multispectral dermoscopy help in distinguishing blue color?

European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023

Cost-of-illness of skin cancer : a systematic literature review

Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial

Truth or dare : switching BRAF/MEK inhibitors after acute interstitial nephritis in a patient with metastatic melanoma : a case report and review of the literature

The therapeutic dilemma of basal cell carcinoma in older adults : a review of the current literature

A critical re‐evaluation of Mohs micrographic surgery for a facial basal cell carcinoma in older adults : should we waive this treatment in certain patients?

Study protocol of the BASINEL Study : a pragmatic randomised controlled trial investigating treatment versus no treatment of low-risk basal cell carcinomas in older persons

Response to the comment by Suijkerbuijk et al. ‘Survival of stage IV melanoma in Belgium and the Netherlands’

Basal cell carcinoma in older adults : how to decide when active surveillance or watchful waiting are appropriate?

Health state utility instruments in patients with keratinocyte cancer and actinic keratosis : a cross‐sectional study

Skin cancer detection using infrared thermography : measurement setup, procedure and equipment

Systemic treatment of advanced basal cell carcinoma : how to critically evaluate value for patient and society?

The value of measuring uncertainty in neural networks in dermoscopy

Towards the discovery of prognostic and predictive biomarkers in CHEERS, a radioimmunotherapy phase II trial

High-resolution 18F-FDG PET/CT for assessing three-dimensional intraoperative margins status in malignancies of the head and neck, a proof-of-concept

Immune monitoring in melanoma and urothelial cancer patients treated with anti-PD-1 immunotherapy and SBRT discloses tumor specific immune signatures

Lesion‐directed screening to optimize skin cancer detection in dermatology practice : an observational study

Three-dimensional margin assessment in head and neck malignancies using a submillimetric 18F-FDG PET/CT, results of an ongoing clinical trial

Clinical relevance of serum Kyn/Trp ratio and basal and IFN gamma-upregulated IDO1 expression in peripheral monocytes in early stage melanoma

Incidence and survival of cutaneous melanoma in Belgium and the Netherlands from 2004 to 2016 : striking differences and similarities of two neighbouring countries

Editorial : targeting indoleamine 2,3-dioxygenases and tryptophan dioxygenase for cancer immunotherapy

Phototoxicité sous olanzapine et acide valproïque : rapport de cas et revue de la littérature sur les effets secondaires au niveau cutané suite aux antipsychotiques atypiques et à l'acide valproïque

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic

A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases

The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype

IDO expression in cancer : different compartment, different functionality?

Enhanced visualization of blood and pigment in multispectral skin dermoscopy

Charting extracellular transcriptomes in the human biofluid RNA atlas

Haptoglobin polymorphism and the risk of actinic keratoses and cutaneous squamous cell carcinoma: A case-control study

Phase 2 trial of nivolumab combined with stereotactic body radiation therapy in patients with metastatic or locally advanced inoperable melanoma

Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results

Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma : clinical and translational results

Assessing uncertainty for computer assisted skin lesion diagnosis

Value of dermoscopy in a population-based screening sample by dermatologists

Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma

A study on confidence in classification of skin lesions by deep neural networks

A study on confidence in classification of skin lesions by deep neural networks

Immune checkpoint blockade for organ transplant patients with advanced cancer : how far can we go?

Algorithms for molecular testing in solid tumours

Endothelial indoleamine 2,3-dioxygenase is correlated with microsatellite status in colorectal carcinoma and predicts worse prognosis